Showing 1 - 10 of 71
Persistent link: https://www.econbiz.de/10005442783
In a recent leading article in PharmacoEconomics, Nuijten described some methods for incorporating uncertainty into health economic models and for utilising the information on uncertainty regarding the cost effectiveness of a therapy in resource allocation decision-making. His proposals are...
Persistent link: https://www.econbiz.de/10004990337
Persistent link: https://www.econbiz.de/10005449031
The modeling of many complex phenomena necessarily relies on numerous interrelated judgments. This paper illustrates an application of the concepts of multiattribute utility assessment, based on the professional judgments of one physician, to scale the trauma severity of injuries to individuals....
Persistent link: https://www.econbiz.de/10009209298
Persistent link: https://www.econbiz.de/10008577293
Persistent link: https://www.econbiz.de/10005508841
Decisions in health care must be made, despite uncertainty about benefits, risks, and costs. Value of information analysis is a theoretically sound method to estimate the expected value of future quantitative research pertaining to an uncertain decision. If the expected value of future research...
Persistent link: https://www.econbiz.de/10005442786
This comprehensive collection brings together more than 50 contributions from some of the most influential researchers in health economics. It authoritatively covers theoretical and empirical issues in health economics, with a balanced range of material on equity and efficiency in health care...
Persistent link: https://www.econbiz.de/10011181857
The aim of The Elgar Companion to Health Economics is to take an audience of advanced undergraduates, postgraduates and researchers to the frontier of research in health economics, by providing them with short and easily readable introductions to key topics. The volume brings together 50...
Persistent link: https://www.econbiz.de/10011172990
Background: A recent study found fewer hospitalizations for congestive heart failure (CHF) patients receiving high-dose versus low-dose statin therapy. Objective: To examine the cost effectiveness of high-dose versus low-dose statin therapy in CHF patients. Methods: Two scenarios...
Persistent link: https://www.econbiz.de/10008556611